Key facts
- This page summarizes Wayne Remell Walker's Form 4 filing for Petros Pharmaceuticals, Inc. (PTPI).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 08 Jun 2026, 17:00.
Key filing fact
Ownership activity is grounded in SEC Form 4 disclosures.
Shares, units, or other non-derivative securities reported in this filing.
Award
Additional SEC filing notes
Footnote F1
Represents restricted shares ("Shares") of common stock, par value $0.0001 per share, of the Issuer. 50% of the Shares vested on the date of grant and the remaining 50% will vest on the six-month anniversary of the date of grant, provided that the Reporting Person is providing services to the Issuer on such vesting date.